Just presented at the 2018 Ada conference, empirical evidence the Tresiba has greater efficacy and fewer Hypo events over Toujo with T2s.
Insulin Degludec Injection Improves A1C, Hypoglycemic Episodes in CONFIRM
2 Likes
It’s almost as if I’ve been singing that from the highest mountain tops for about 3 years
4 Likes
@Sam I migrated from Lantus to Tresiba before I went on a pump and LOVED it! No spikes, no stacking, and leniency with dosage times. A dream come true
Tresiba is lucky to have you as an unofficial spokesperson
3 Likes